Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 22.85M P/E - EPS this Y 52.10% Ern Qtrly Grth -
Income -31.57M Forward P/E -0.61 EPS next Y -23.50% 50D Avg Chg -15.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -37.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -67.00%
Recommedations 2.00 Quick Ratio 0.52 Shares Outstanding 54.52M 52W Low Chg 26.00%
Insider Own 53.41% ROA -95.05% Shares Float 21.11M Beta 2.35
Inst Own 2.95% ROE - Shares Shorted/Prior 2.13M/0.96M Price 0.72
Gross Margin - Profit Margin - Avg. Volume 926,735 Target Price 5.25
Oper. Margin - Earnings Date May 9 Volume 657,961 Change -0.01%
About Better Therapeutics, Inc.

Better Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company's lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions. In addition, the company's clinical development candidates are intended to treat cardiometabolic diseases, including type 2 diabetes, hypertension, hyperlipidemia, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and chronic kidney disease. Its product pipeline also includes BT-002, which intends glycemic control for hypertension; BT-003 to reduce LDL cholesterol in patients with hyperlipidemia; and BT-004, which intends to explore the impact of treatment on liver health in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease. The company was founded in 2015 and is headquartered in San Francisco, California.

Better Therapeutics, Inc. News
03/14/24 Better Therapeutics Announces it will Seek Strategic Alternatives and will be Delisted from Nasdaq
03/05/24 Better Therapeutics Announces an Innovative Partnership with the American College of Lifestyle Medicine to Expand Access to AspyreRx Across 1,400 Federally Qualified Health Centers
03/04/24 Better Therapeutics Announces Acceptance of Late Breaking Abstract for Its AspyreRx Pivotal Trial 180 Day Outcomes and Participation at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
03/01/24 Better Therapeutics and Biotricity Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
02/20/24 Better Therapeutics Receives FDA Breakthrough Device Designation for Digital Therapeutic Platform Targeting Advanced Liver Disease
02/06/24 Better Therapeutics Signs Rebate Agreement with One of the Largest Pharmacy Benefit Managers in the US for its AspyreRx Diabetes Treatment
01/18/24 David Perry Bought 8.6% More Shares In Better Therapeutics
01/17/24 Better Therapeutics Announces Publication of Cost-Effectiveness Analysis Demonstrating AspyreRx is More Effective and Less Costly than Standard of Care Alone
01/04/24 Better Therapeutics and Glooko Announce Partnership to Accelerate Adoption of AspyreRx to Treat Type 2 Diabetes in the United States
01/03/24 Better Therapeutics Insiders Added US$6.57m Of Stock To Their Holdings
01/02/24 Better Therapeutics Announces Submission for FDA Breakthrough Device Designation for Digital Therapeutic Platform to Treat Liver Disease
11/28/23 Better Therapeutics Strengthens Financial Position Through Amendment to Debt Facility and Implementation of Cost Reductions
11/14/23 Frost & Sullivan Honors Better Therapeutics with the 2023 Technology Innovation Leadership Award
11/09/23 Better Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates
11/08/23 Better Therapeutics to Release Third Quarter 2023 Financial Results and Provide Business Update on November 09, 2023
10/26/23 Better Therapeutics to Participate in the American College of Lifestyle Medicine’s 2023 Annual Conference
10/16/23 Better Therapeutics Announces Launch of AspyreRxTM to Treat Adults with Type 2 Diabetes
10/11/23 Better Therapeutics Announces New Data Highlighting Concurrent Use of AspyreRx and GLP-1 Receptor Agonists to Treat Type 2 Diabetes
10/05/23 Better Therapeutics Announces Publication of LivVita Liver Disease Study Results in Gastro Hep Advances
09/28/23 Better Therapeutics Completes Enrollment in Real-World Evidence Program Evaluating Long-term Effectiveness of AspyreRx in Type 2 Diabetes
BTTX Chatroom

User Image Zardiw Posted - 13 hours ago

$BTTX Market Cap $600K and they have $6M Cash Z

User Image Zardiw Posted - 13 hours ago

$BTTX - Easter Special - Super Bounce? Has dropped 92% from $1+ price only 8 months ago https://www.youtube.com/watch?v=LHkWQnPTZyA Z

User Image Jack1312 Posted - 15 hours ago

$BTTX And the YouTuber also says it a few times that it's actually a great company! Could probably be bought up and then we'd be rich men 💸💸💸🤑

User Image Jack1312 Posted - 15 hours ago

$BTTX They have customized their website…

User Image Jack1312 Posted - 15 hours ago

$BTTX

User Image Zardiw Posted - 15 hours ago

$BTTX - #DDAmanda Video Analysis: https://www.youtube.com/watch?v=LHkWQnPTZyA Z

User Image Homer_Simpson82 Posted - 16 hours ago

$BTTX next Red day

User Image Homer_Simpson82 Posted - 17 hours ago

$BTTX Dumping

User Image Zardiw Posted - 17 hours ago

$BTTX Looking for a bounce here on $BTTX.......Market Cap now is $600K and they have $6M Cash............ Z

User Image BADX_Hustla Posted - 19 hours ago

$BTTX thats right gtf back to nasdaq

User Image Avanzas Posted - 20 hours ago

$BTTX Today is the day 🚀🚀 can't be any sellers left

User Image PaytiencePaysGreen Posted - 22 hours ago

$NDRA $GMDA $BTTX

User Image Homer_Simpson82 Posted - 1 day ago

$BTTX eow 0.01

User Image TheGoatBull Posted - 1 day ago

$BTTX what’s odd is all the employees that has bttx in their linkedin profile is still “employed” and haven’t been searching for a job (just my assumption) If i was laid off id update my resume and start searching immediately. Just hopeful thoughts could be nothing who knows 🫣

User Image Doge0820 Posted - 1 day ago

$BTTX

User Image Homer_Simpson82 Posted - 1 day ago

$BTTX Dumping 👍👍

User Image Jack1312 Posted - 1 day ago

$BTTX @Avanzas You're not alone Bro 💪 Of course I'm also holding because, as I said, it makes no sense to sell... I even bought more to lower the average💪

User Image DAKX Posted - 1 day ago

$BTTX It's desperately trying! Gotta give it credit for that🤣

User Image Homer_Simpson82 Posted - 1 day ago

$BTTX next Red day 🤣

User Image Stock_wits1 Posted - 1 day ago

$BTTX I think weak hands are already out. Just with a flash of one positive news will fire it up.

User Image Avanzas Posted - 1 day ago

$BTTX What happened has everyone sold out? Am I the only idiot left?

User Image Avanzas Posted - 1 day ago

$BTTX

User Image Homer_Simpson82 Posted - 1 day ago

$BTTX this Shit is done. See you under 0.01

User Image Theshermank Posted - 2 days ago

$BTTX delist

User Image snugmunchkin Posted - 2 days ago

$BTTX That gap potential is tempting, but I wouldnt bet a lot of money on it lol.

User Image Homer_Simpson82 Posted - 2 days ago

$BTTX maybe tomorrow 0.01

User Image Homer_Simpson82 Posted - 2 days ago

$BTTX scam Stock 🤣🤣😉😉

User Image Jack1312 Posted - 2 days ago

$BTTX According to my broker they will present the pre market numbers tomorrow 3/27/24. Hope and have a good feeling 🚀🚀🚀

User Image Jack1312 Posted - 2 days ago

$BTTX Bro that Homer Simpsons I've blocked for a long time... It's a shame for this legendary name

User Image Homer_Simpson82 Posted - 2 days ago

$BTTX from 0.02 and now 0.0135🤣🤣

Analyst Ratings
Lake Street Buy Aug 10, 23
Chardan Capital Buy Aug 10, 23
Lake Street Buy Apr 14, 23
Chardan Capital Buy Mar 31, 23
Chardan Capital Buy Nov 15, 22
Chardan Capital Buy Jul 29, 22
Chardan Capital Buy Mar 16, 22
Chardan Capital Buy Nov 24, 21
Cowen & Co. Outperform Nov 10, 21
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
PERRY DAVID P Executive Chairman Executive Chairman Jul 27 Buy 0.7299 1,233,045 900,000 13,030,393 07/31/23
Berman Mark A. Chief Medical Office.. Chief Medical Officer Jul 27 Buy 0.7299 54,802 40,000 388,191 07/31/23
Armanino Andrew J. Director Director Jul 27 Buy 0.7299 274,010 200,000 728,368 07/31/23
Granger Elder Director Director Jul 27 Buy 0.7299 34,251 25,000 35,851 07/31/23
KARBE FRANK Chief Executive Offi.. Chief Executive Officer Jul 27 Buy 0.7299 137,005 100,000 429,429 07/31/23
Parker Geoffrey M. Director Director Jul 27 Buy 0.7299 685,025 500,000 1,028,055 07/31/23
Granger Elder Director Director May 16 Buy 0.8672 600 520 1,600 05/18/23
PERRY DAVID P See Remarks See Remarks Apr 10 Buy 0.83 4,969,697 4,124,849 3,636,364 04/12/23
PERRY DAVID P See Remarks See Remarks Sep 15 Buy 2.03 50,000 101,500 101,536 09/19/22
KARBE FRANK See Remarks See Remarks Sep 15 Buy 2.0939 50,000 104,695 50,000 09/15/22
Armanino Andrew J. Director Director Jun 14 Buy 1.3897 15,000 20,846 15,000 06/16/22
Heinen Mark See Remarks See Remarks Jun 10 Buy 1.56 5,000 7,800 20,000 06/10/22
Zamirowski Justin Chief Commercial Off.. Chief Commercial Officer May 16 Option 0.50 35,236 17,618 35,236 05/18/22
Armanino Andrew J. Director Director Mar 29 Buy 2.1405 40,000 85,620 126,328 03/31/22
Parker Geoffrey M. Director Director Mar 29 Buy 2.1487 15,000 32,230 15,000 03/31/22